Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pediatric Hematology/Oncology
•
Hematology
•
Pediatric Hematology
What is your criteria for considering oral, or IV, iron repletion in pediatric patients referred to Hematology for restless leg syndrome?
Related Questions
Is there any indication for IVIG in immunocompromised patients with only decreased IgM and/or IgA levels?
What is your preferred treatment for refractory warm autoimmune hemolytic anemia with autoimmune neutropenia?
What is your approach to screening a cancer survivor for iron overload, and what is your treatment of choice?
What is your experience with managing patients with STEAP3 mutation and non-transfusion related iron overload?
In patients with lupus nephritis, and MAHA with positive anti-phospholipid autoantibodies, what are the considerations to use or not use anti-coagulation therapy?
How should clinicians approach the decision to use apixaban, or other DOACs, in pediatric patients with acute lymphoblastic leukemia or lymphoma who have additional risk factors for VTE, such as obesity or a family history of thrombosis, given the negative outcome of the PREVAPIX-ALL trial?
In an adult patient with asymptomatic, isolated neutropenia in whom you suspect a Duffy null phenotype, at what ANC or in what situations would you do a bone marrow to look for other etiologies of neutropenia?
How do you counsel sickle cell patients on the use of G-CSF to treat neutropenia from other causes, like malignancy?
What workup needs to be performed on pediatric patients with warm autoimmune hemolytic anemia prior to initiation of treatment with immunosuppressants?
How do you manage significant asymptomatic indirect hyperbilirubinemia in patients with hemolytic diseases (SCD, HS, etc.)?
